Aduro BioTech, Inc. (Aduro)

Oncology Corporate Profile

HQ Location

626 Bancroft Way, #3C
Berkeley, CA 94710

Company Description

Aduro BioTech, Inc. is a clinical-stage immunotherapy company located in Berkeley, California. Aduro has completed a randomized, controlled Phase 2 clinical trial in patients with metastatic pancreatic cancer and is conducting a Phase 1B trial in patients with malignant pleural mesothelioma. The company's pipeline also includes preclinical programs in glioblastoma, prostate cancer, melanoma, malaria, HBV and tularemia.

Website: http://www.adurobiotech.com/

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
GVAX vaccine / CRS-207immunotherapyGastric cancerII
GVAX vaccine / CRS-207 (+pembrolizumab)immunotherapyMesotheliomaII
pLADDimmunotherapyColorectal cancerI
pLADDimmunotherapyGastric cancerI
Anti-APRILimmunotherapyMultiple MyelomaI
ADU-741immunotherapyNon Small Cell Lung Cancer (NSCLC)IJanssen
GVAX vaccine / CRS-207immunotherapyOvarian cancerIIncyte
ADU-741immunotherapyProstate cancerIJanssen
ADU-S100immunotherapyVarious cancer typesINovartis

View additional information on product candidates here »

Source: http://www.adurobiotech.com/

Recent News Headlines

There are no news items to display